China’s Lepu Biopharma reports H1 revenue up 12.1%
Lepu Biopharma says its H1 revenue increased 12.1% year over year, driven by higher drug sales.
OverviewOutlookResult DriversKey DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.